|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 801 to 900 out of 1236 for Cdkn2a

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.036s

Categories

Category: Publication
« show all
Type Details Score
Publication
22751500 | J:185344
First Author: Chen AJ
Year: 2012
Journal: Genes Dev
Title: STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA.
Volume: 26
Issue: 13
Pages: 1459-72
•
•
•
•
•
Publication
26418719 | J:316142
First Author: Peyre M
Year: 2015
Journal: Oncotarget
Title: PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.
Volume: 6
Issue: 32
Pages: 32713-22
•
•
•
•
•
Publication
23401854 | J:203321
First Author: Zhang Y
Year: 2013
Journal: Mol Cell Biol
Title: P19ARF and RasV¹² offer opposing regulation of DHX33 translation to dictate tumor cell fate.
Volume: 33
Issue: 8
Pages: 1594-607
•
•
•
•
•
Publication
24632607 | J:218621
First Author: Camacho CV
Year: 2015
Journal: Oncogene
Title: DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification.
Volume: 34
Issue: 8
Pages: 1064-72
•
•
•
•
•
Publication
25712345 | J:220158
First Author: Scortegagna M
Year: 2015
Journal: Cancer Res
Title: PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets.
Volume: 75
Issue: 7
Pages: 1399-412
•
•
•
•
•
Publication
25990896 | J:224786
First Author: Carrasco-Garcia E
Year: 2015
Journal: Aging Cell
Title: Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional decline.
Volume: 14
Issue: 4
Pages: 710-4
•
•
•
•
•
Publication
28985506 | J:251938
First Author: Chen D
Year: 2017
Journal: Mol Cell
Title: NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression.
Volume: 68
Issue: 1
Pages: 224-232.e4
•
•
•
•
•
Publication
27664376 | J:317254
First Author: Azzopardi S
Year: 2016
Journal: Neoplasia
Title: p53 and p16Ink4a/p19Arf Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells.
Volume: 18
Issue: 10
Pages: 610-617
•
•
•
•
•
Publication
15361884 | J:93211
First Author: Qi Y
Year: 2004
Journal: Nature
Title: p19ARF directly and differentially controls the functions of c-Myc independently of p53.
Volume: 431
Issue: 7009
Pages: 712-7
•
•
•
•
•
Publication
22561347 | J:185559
First Author: Chio II
Year: 2012
Journal: Nat Cell Biol
Title: TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation.
Volume: 14
Issue: 6
Pages: 625-33
•
•
•
•
•
Publication
28463229 | J:244758
First Author: Olvedy M
Year: 2017
Journal: J Clin Invest
Title: Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.
Volume: 127
Issue: 6
Pages: 2310-2325
•
•
•
•
•
Publication
19524511 | J:157347
First Author: Inomata K
Year: 2009
Journal: Cell
Title: Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation.
Volume: 137
Issue: 6
Pages: 1088-99
•
•
•
•
•
Publication
21512139 | J:172206
First Author: Young NP
Year: 2011
Journal: Cancer Res
Title: Uncoupling cancer mutations reveals critical timing of p53 loss in sarcomagenesis.
Volume: 71
Issue: 11
Pages: 4040-7
•
•
•
•
•
Publication
17392427 | J:120371
First Author: Stecca B
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways.
Volume: 104
Issue: 14
Pages: 5895-900
•
•
•
•
•
Publication
28746871 | J:254287
First Author: Zingg D
Year: 2017
Journal: Cell Rep
Title: The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy.
Volume: 20
Issue: 4
Pages: 854-867
•
•
•
•
•
Publication
21075310 | J:166831
First Author: Lee KE
Year: 2010
Journal: Cancer Cell
Title: Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells.
Volume: 18
Issue: 5
Pages: 448-58
•
•
•
•
•
Publication
36351408 | J:331107
First Author: Ramakrishnan G
Year: 2022
Journal: Cell Rep
Title: NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma.
Volume: 41
Issue: 6
Pages: 111623
•
•
•
•
•
Publication
31896747 | J:284826
First Author: He D
Year: 2020
Journal: Nat Commun
Title: Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway.
Volume: 11
Issue: 1
Pages: 37
•
•
•
•
•
Publication
34284046 | J:314692
     
First Author: Zhu X
Year: 2021
Journal: J Invest Dermatol
Title: HDAC1/2 Control Proliferation and Survival in Adult Epidermis and Pre‒Basal Cell Carcinoma through p16 and p53.
•
•
•
•
•
Publication
25157181 | J:218704
First Author: Rodríguez-Díez E
Year: 2014
Journal: Blood
Title: Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis.
Volume: 124
Issue: 15
Pages: 2380-90
•
•
•
•
•
Publication
22729085 | J:190763
First Author: Kua HY
Year: 2012
Journal: Nat Cell Biol
Title: c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression.
Volume: 14
Issue: 7
Pages: 727-37
•
•
•
•
•
Publication
16397221 | J:105031
First Author: Hruban RH
Year: 2006
Journal: Cancer Res
Title: Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
Volume: 66
Issue: 1
Pages: 95-106
•
•
•
•
•
Publication
25605372 | J:221399
First Author: Sheikh BN
Year: 2015
Journal: Blood
Title: MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development.
Volume: 125
Issue: 12
Pages: 1910-21
•
•
•
•
•
Publication
22907756 | J:189250
First Author: Widau RC
Year: 2012
Journal: Mol Cell Biol
Title: p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.
Volume: 32
Issue: 21
Pages: 4270-82
•
•
•
•
•
Publication
15665276 | J:95440
First Author: Pantoja C
Year: 2005
Journal: Cancer Res
Title: Inactivation of imprinted genes induced by cellular stress and tumorigenesis.
Volume: 65
Issue: 1
Pages: 26-33
•
•
•
•
•
Publication
15870287 | J:99136
First Author: Bardeesy N
Year: 2005
Journal: Mol Cell Biol
Title: Role of epidermal growth factor receptor signaling in RAS-driven melanoma.
Volume: 25
Issue: 10
Pages: 4176-88
•
•
•
•
•
Publication
19321450 | J:150510
First Author: Kim J
Year: 2009
Journal: J Biol Chem
Title: Oxidative stress is linked to ERK1/2-p16 signaling-mediated growth defect in ATM-deficient astrocytes.
Volume: 284
Issue: 21
Pages: 14396-404
•
•
•
•
•
Publication
23933255 | J:201893
First Author: Putz EM
Year: 2013
Journal: Cell Rep
Title: CDK8-mediated STAT1-S727 phosphorylation restrains NK cell cytotoxicity and tumor surveillance.
Volume: 4
Issue: 3
Pages: 437-44
•
•
•
•
•
Publication
29808009 | J:336458
First Author: Ruess DA
Year: 2018
Journal: Nat Med
Title: Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase.
Volume: 24
Issue: 7
Pages: 954-960
•
•
•
•
•
Publication
23754744 | J:204567
First Author: Shamma A
Year: 2013
Journal: Mol Cell Biol
Title: ATM mediates pRB function to control DNMT1 protein stability and DNA methylation.
Volume: 33
Issue: 16
Pages: 3113-24
•
•
•
•
•
Publication
17676052 | J:125101
First Author: Kirsch DG
Year: 2007
Journal: Nat Med
Title: A spatially and temporally restricted mouse model of soft tissue sarcoma.
Volume: 13
Issue: 8
Pages: 992-7
•
•
•
•
•
Publication
17632527 | J:126550
First Author: Dierks C
Year: 2007
Journal: Nat Med
Title: Essential role of stromally induced hedgehog signaling in B-cell malignancies.
Volume: 13
Issue: 8
Pages: 944-51
•
•
•
•
•
Publication
17114584 | J:116130
First Author: Bardeesy N
Year: 2006
Journal: Genes Dev
Title: Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
Volume: 20
Issue: 22
Pages: 3130-46
•
•
•
•
•
Publication
25252692 | J:220627
First Author: Burd CE
Year: 2014
Journal: Cancer Discov
Title: Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma.
Volume: 4
Issue: 12
Pages: 1418-29
•
•
•
•
•
Publication
22611036 | J:187012
First Author: Singh M
Year: 2012
Journal: J Pathol
Title: Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models.
Volume: 227
Issue: 4
Pages: 417-30
•
•
•
•
•
Publication
17676035 | J:124682
First Author: Ji H
Year: 2007
Journal: Nature
Title: LKB1 modulates lung cancer differentiation and metastasis.
Volume: 448
Issue: 7155
Pages: 807-10
•
•
•
•
•
Publication
23266956 | J:195229
First Author: Lo B
Year: 2012
Journal: J Cell Biol
Title: Lkb1 regulates organogenesis and early oncogenesis along AMPK-dependent and -independent pathways.
Volume: 199
Issue: 7
Pages: 1117-30
•
•
•
•
•
Publication
15894267 | J:98936
First Author: Hingorani SR
Year: 2005
Journal: Cancer Cell
Title: Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.
Volume: 7
Issue: 5
Pages: 469-83
•
•
•
•
•
Publication
23453624 | J:197054
First Author: Eser S
Year: 2013
Journal: Cancer Cell
Title: Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer.
Volume: 23
Issue: 3
Pages: 406-20
•
•
•
•
•
Publication
27135738 | J:239472
First Author: Souroullas GP
Year: 2016
Journal: Nat Med
Title: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
Volume: 22
Issue: 6
Pages: 632-40
•
•
•
•
•
Publication
23845441 | J:199307
First Author: Rad R
Year: 2013
Journal: Cancer Cell
Title: A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention.
Volume: 24
Issue: 1
Pages: 15-29
•
•
•
•
•
Publication
17299132 | J:121715
First Author: Dankort D
Year: 2007
Journal: Genes Dev
Title: A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors.
Volume: 21
Issue: 4
Pages: 379-84
•
•
•
•
•
Publication
15210712 | J:92528
First Author: Carstens MJ
Year: 2004
Journal: J Biol Chem
Title: Cell cycle arrest and cell death are controlled by p53-dependent and p53-independent mechanisms in Tsg101-deficient cells.
Volume: 279
Issue: 34
Pages: 35984-94
•
•
•
•
•
Publication
31804490 | J:286711
First Author: Rodríguez-Hernández G
Year: 2019
Journal: Nat Commun
Title: Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID.
Volume: 10
Issue: 1
Pages: 5563
•
•
•
•
•
Publication
17576930 | J:122592
First Author: Ha L
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence.
Volume: 104
Issue: 26
Pages: 10968-73
•
•
•
•
•
Publication
18591425 | J:139257
First Author: Mudhasani R
Year: 2008
Journal: J Cell Biol
Title: Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells.
Volume: 181
Issue: 7
Pages: 1055-63
•
•
•
•
•
Publication
20048081 | J:155731
First Author: Held MA
Year: 2010
Journal: Cancer Res
Title: Characterization of melanoma cells capable of propagating tumors from a single cell.
Volume: 70
Issue: 1
Pages: 388-97
•
•
•
•
•
Publication
33020472 | J:298638
First Author: De Boeck A
Year: 2020
Journal: Nat Commun
Title: Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.
Volume: 11
Issue: 1
Pages: 4997
•
•
•
•
•
Publication
26711264 | J:236205
First Author: Calés C
Year: 2015
Journal: Mol Cell Biol
Title: Role of Polycomb RYBP in Maintaining the B-1-to-B-2 B-Cell Lineage Switch in Adult Hematopoiesis.
Volume: 36
Issue: 6
Pages: 900-12
•
•
•
•
•
Publication
32639068 | J:297579
First Author: Chen Z
Year: 2020
Journal: Glia
Title: Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade.
Volume: 68
Issue: 10
Pages: 2148-2166
•
•
•
•
•
Publication
15967113 | J:100163
First Author: Hu X
Year: 2005
Journal: Neoplasia
Title: mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
Volume: 7
Issue: 4
Pages: 356-68
•
•
•
•
•
Publication
33323974 | J:302562
First Author: Swoboda A
Year: 2021
Journal: Oncogene
Title: STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.
Volume: 40
Issue: 6
Pages: 1091-1105
•
•
•
•
•
Publication
30355677 | J:271155
First Author: Hill KS
Year: 2019
Journal: Mol Cancer Res
Title: PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas.
Volume: 17
Issue: 2
Pages: 583-593
•
•
•
•
•
Publication
28394259 | J:244425
First Author: Huang Y
Year: 2017
Journal: J Clin Invest
Title: A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma.
Volume: 127
Issue: 5
Pages: 1826-1838
•
•
•
•
•
Publication
26904942 | J:266022
First Author: Danis E
Year: 2016
Journal: Cell Rep
Title: Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.
Volume: 14
Issue: 8
Pages: 1953-65
•
•
•
•
•
Publication
28836293 | J:252858
First Author: Herting CJ
Year: 2017
Journal: Glia
Title: Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
Volume: 65
Issue: 12
Pages: 1914-1926
•
•
•
•
•
Publication
28497782 | J:335349
 
First Author: Dorard C
Year: 2017
Journal: Nat Commun
Title: RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma.
Volume: 8
Pages: 15262
•
•
•
•
•
Publication
22836752 | J:191329
First Author: Yang J
Year: 2012
Journal: Cancer Res
Title: INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma.
Volume: 72
Issue: 18
Pages: 4682-95
•
•
•
•
•
Publication
33592194 | J:352355
First Author: Kälin RE
Year: 2021
Journal: Cell Syst
Title: TAMEP are brain tumor parenchymal cells controlling neoplastic angiogenesis and progression.
Volume: 12
Issue: 3
Pages: 248-262.e7
•
•
•
•
•
Publication
21177767 | J:170376
First Author: Picchione F
Year: 2011
Journal: Carcinogenesis
Title: IRIZIO: a novel gene cooperating with PAX3-FOXO1 in alveolar rhabdomyosarcoma (ARMS).
Volume: 32
Issue: 4
Pages: 452-61
•
•
•
•
•
Publication
22698401 | J:189285
First Author: Liu W
Year: 2012
Journal: Cancer Cell
Title: LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.
Volume: 21
Issue: 6
Pages: 751-64
•
•
•
•
•
Publication
37733448 | J:342600
 
First Author: Chen Z
Year: 2023
Journal: J Clin Invest
Title: A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression.
Volume: 133
Issue: 22
•
•
•
•
•
Publication
28235764 | J:242079
First Author: Chen Z
Year: 2017
Journal: Cancer Res
Title: Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma.
Volume: 77
Issue: 9
Pages: 2266-2278
•
•
•
•
•
Publication
25778535 | J:223783
First Author: Alemdehy MF
Year: 2015
Journal: Blood
Title: ICL-induced miR139-3p and miR199a-3p have opposite roles in hematopoietic cell expansion and leukemic transformation.
Volume: 125
Issue: 25
Pages: 3937-48
•
•
•
•
•
Publication
23332765 | J:193498
First Author: Burd CE
Year: 2013
Journal: Cell
Title: Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model.
Volume: 152
Issue: 1-2
Pages: 340-51
•
•
•
•
•
Publication
11551927 | J:72780
First Author: Paramio JM
Year: 2001
Journal: J Biol Chem
Title: The ink4a/arf tumor suppressors cooperate with p21cip1/waf in the processes of mouse epidermal differentiation, senescence, and carcinogenesis.
Volume: 276
Issue: 47
Pages: 44203-11
•
•
•
•
•
Publication
25939753 | J:222769
First Author: Bednar F
Year: 2015
Journal: Carcinogenesis
Title: Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism.
Volume: 36
Issue: 7
Pages: 730-8
•
•
•
•
•
Publication
33626352 | J:304305
First Author: Tomita H
Year: 2021
Journal: Cell Rep
Title: Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas.
Volume: 34
Issue: 8
Pages: 108772
•
•
•
•
•
Publication
23079662 | J:192027
First Author: Hatley ME
Year: 2012
Journal: Cancer Cell
Title: A mouse model of rhabdomyosarcoma originating from the adipocyte lineage.
Volume: 22
Issue: 4
Pages: 536-46
•
•
•
•
•
Publication
20571512 | J:197818
First Author: Wilting RH
Year: 2010
Journal: EMBO J
Title: Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis.
Volume: 29
Issue: 15
Pages: 2586-97
•
•
•
•
•
Publication
21242963 | J:173718
First Author: Kalamarides M
Year: 2011
Journal: Oncogene
Title: Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes.
Volume: 30
Issue: 20
Pages: 2333-44
•
•
•
•
•
Publication
29334315 | J:333235
First Author: Zalzali H
Year: 2018
Journal: Cell Cycle
Title: Interplay between p53 and Ink4c in spermatogenesis and fertility.
Volume: 17
Issue: 5
Pages: 643-651
•
•
•
•
•
Publication
26314219 | J:225962
First Author: Sachdeva M
Year: 2015
Journal: Cancer Lett
Title: Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182.
Volume: 369
Issue: 1
Pages: 202-11
•
•
•
•
•
Publication
29364867 | J:257934
First Author: Mueller S
Year: 2018
Journal: Nature
Title: Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
Volume: 554
Issue: 7690
Pages: 62-68
•
•
•
•
•
Publication
26438692 | J:226536
First Author: Gopinathan A
Year: 2015
Journal: Dis Model Mech
Title: GEMMs as preclinical models for testing pancreatic cancer therapies.
Volume: 8
Issue: 10
Pages: 1185-200
•
•
•
•
•
Publication
26390243 | J:228905
First Author: Mazur PK
Year: 2015
Journal: Nat Med
Title: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
Volume: 21
Issue: 10
Pages: 1163-71
•
•
•
•
•
Publication
20718941 | J:222847
First Author: Ferguson B
Year: 2010
Journal: Pigment Cell Melanoma Res
Title: Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis.
Volume: 23
Issue: 6
Pages: 771-80
•
•
•
•
•
Publication
27841882 | J:260936
First Author: Shingu T
Year: 2017
Journal: Nat Genet
Title: Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.
Volume: 49
Issue: 1
Pages: 75-86
•
•
•
•
•
Publication
21613822 | J:349147
First Author: Sempere LF
Year: 2011
Journal: Cancer Biol Ther
Title: A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells.
Volume: 12
Issue: 3
Pages: 198-207
•
•
•
•
•
Publication
25119024 | J:217085
First Author: Viale A
Year: 2014
Journal: Nature
Title: Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function.
Volume: 514
Issue: 7524
Pages: 628-32
•
•
•
•
•
Publication
34535684 | J:312395
First Author: Langdon CG
Year: 2021
Journal: Nat Commun
Title: Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity.
Volume: 12
Issue: 1
Pages: 5520
•
•
•
•
•
Publication
22265420 | J:181291
First Author: Rhim AD
Year: 2012
Journal: Cell
Title: EMT and dissemination precede pancreatic tumor formation.
Volume: 148
Issue: 1-2
Pages: 349-61
•
•
•
•
•
Publication
23267082 | J:193286
First Author: Kowalska E
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: NONO couples the circadian clock to the cell cycle.
Volume: 110
Issue: 5
Pages: 1592-9
•
•
•
•
•
Publication
29438700 | J:257785
First Author: Yu Y
Year: 2018
Journal: Cancer Cell
Title: Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.
Volume: 33
Issue: 2
Pages: 322-336.e8
•
•
•
•
•
Publication
20832751 | J:164200
First Author: Macias E
Year: 2010
Journal: Cancer Cell
Title: An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.
Volume: 18
Issue: 3
Pages: 231-43
•
•
•
•
•
Publication
17200204 | J:117199
First Author: Schubert W
Year: 2007
Journal: Am J Pathol
Title: Caveolin-1(-/-)- and caveolin-2(-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation.
Volume: 170
Issue: 1
Pages: 316-33
•
•
•
•
•
Publication
19246386 | J:146777
First Author: Tian H
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis.
Volume: 106
Issue: 11
Pages: 4254-9
•
•
•
•
•
Publication
35523176 | J:325642
First Author: Huang H
Year: 2022
Journal: Cancer Cell
Title: Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer.
Volume: 40
Issue: 6
Pages: 656-673.e7
•
•
•
•
•
Publication
22391448 | J:181616
First Author: Mallen-St Clair J
Year: 2012
Journal: Genes Dev
Title: EZH2 couples pancreatic regeneration to neoplastic progression.
Volume: 26
Issue: 5
Pages: 439-44
•
•
•
•
•
Publication
26206560 | J:225897
First Author: Kirane A
Year: 2015
Journal: Cancer Res
Title: Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.
Volume: 75
Issue: 18
Pages: 3699-705
•
•
•
•
•
Publication
30938713 | J:308939
   
First Author: Cruz VH
Year: 2019
Journal: JCI Insight
Title: Axl-mediated activation of TBK1 drives epithelial plasticity in pancreatic cancer.
Volume: 5
•
•
•
•
•
Publication
27267807 | J:232848
First Author: Gore J
Year: 2016
Journal: Cancer Lett
Title: Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.
Volume: 379
Issue: 1
Pages: 143-53
•
•
•
•
•
Publication
23580573 | J:197041
First Author: Horiguchi M
Year: 2013
Journal: Cancer Res
Title: Rhythmic control of the ARF-MDM2 pathway by ATF4 underlies circadian accumulation of p53 in malignant cells.
Volume: 73
Issue: 8
Pages: 2639-49
•
•
•
•
•
Publication
28780076 | J:262366
First Author: Liu X
Year: 2017
Journal: Gastroenterology
Title: BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3.
Volume: 153
Issue: 6
Pages: 1607-1620
•
•
•
•
•
Publication
25107471 | J:216065
First Author: Xu CR
Year: 2014
Journal: EMBO J
Title: Dynamics of genomic H3K27me3 domains and role of EZH2 during pancreatic endocrine specification.
Volume: 33
Issue: 19
Pages: 2157-70
•
•
•
•
•
Publication
27578795 | J:240484
First Author: Snitow M
Year: 2016
Journal: Development
Title: Ezh2 restricts the smooth muscle lineage during mouse lung mesothelial development.
Volume: 143
Issue: 20
Pages: 3733-3741
•
•
•
•
•
Publication
29719265 | J:270804
First Author: Philip B
Year: 2018
Journal: Cell Rep
Title: Mutant IDH1 Promotes Glioma Formation In Vivo.
Volume: 23
Issue: 5
Pages: 1553-1564
•
•
•
•
•
Publication
24958854 | J:212177
First Author: Collins C
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis.
Volume: 111
Issue: 27
Pages: 9899-904
•
•
•
•
•
Publication
24200692 | J:207627
First Author: Marsh Durban V
Year: 2013
Journal: J Clin Invest
Title: Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.
Volume: 123
Issue: 12
Pages: 5104-18
•
•
•
•
•
Publication
31048499 | J:276334
First Author: Yoo JH
Year: 2019
Journal: Cancer Res
Title: The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic State.
Volume: 79
Issue: 11
Pages: 2892-2908
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom